GE e-Speed finds a home

Article

The latest version of electron-beam tomography, e-Speed, has been installed at Edward Heart Hospital in Naperville, IL. The hospital is among the first three sites in the world to install the EBT system, which GE Medical Systems acquired through its

The latest version of electron-beam tomography, e-Speed, has been installed at Edward Heart Hospital in Naperville, IL. The hospital is among the first three sites in the world to install the EBT system, which GE Medical Systems acquired through its corporate takeover of Imatron in December 2001 (SCAN 1/2/02). The EBT product is dedicated to cardiology and was introduced last year at the annual meeting of the American Heart Association (SCAN 11/27/03). GE released in mid-May at the annual meeting of the North American Society of Pacing and Electrophysiology a cardiac CT software application dedicated to electrophysiology. The software, called CardEP, includes tools designed to assist the assessment of complex cardiac anatomy. Features include interactive 3D modeling and segmentation.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.